Search results
Results from the WOW.Com Content Network
George A. Scangos was a pharmaceutical executive and former chief executive officer of Vir Biotechnology from 2017 to 2023. Scangos was previously the chief executive officer of Biogen from 2010 to 2016 and of Exelixis from 1996 to 2010.
San Diego Business Journal; San Diego City Beat; San Diego Jewish Journal; San Diego Magazine; San Diego Reader; San Diego Union-Tribune (acquired by Tribune Publishing) Times of San Diego; Retail. Le Travel Store (closed) Mor Furniture; Petco; PriceSmart; Sports. BikeBandit; BMC USA; Competitor Group, Inc. Ellsworth Handcrafted Bicycles ...
The San Jose BioCenter is a business incubator formed as a university foundation in 2004 and focused on the initiation and development of technology companies, with an emphasis on the life sciences industry. [1] [2] The BioCenter emerged from San Jose State University in an effort to revitalize an industrial area of San Jose, California. [1]
In 2015, Fort Felker, former director of the National Wind Technology Center at the National Renewable Energy Laboratory (NREL) was hired as CEO. [7] In December 2016, Makani operated for the first time a 600 kW prototype with 28 meter wing span. [8] [9] Starting August 2018, Makani operated an energy kite test site on the Big Island of Hawaii ...
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California.Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
Egger started her on-air work in San Diego, California, appearing on ITV Cable 16 in August 2004. [4] She moved to become the lead weather anchor on KIFI-TV in Idaho Falls, Idaho in 2006. [4] She subsequently moved to Denver, Colorado, where she served as KDVR's from 2007 through 2010. [4] [5] While in Denver, she covered the 2008 Windsor ...
William H. (aka Bill) Rastetter (born 1948), a scientist, entrepreneur and venture capitalist, is the chair of Neurocrine Biosciences, of Fate Therapeutics, [4] and of Daré Bioscience, Inc. [5] in San Diego, California. He was a founding board member and investor in GRAIL, Inc. in Menlo Park, California, and served for a period as the company ...
It is headquartered in San Diego, California, and led by CEO Kevin Gorman. [3] Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD).